Urology

The guidelines endorse adjuvant nivolumab for patients with pT3/4 and/or pN+ disease who are unsuitable for, or have declined, cisplatin-based chemotherapy.

Importantly, 30% mean reductions in prostate volume were sustained up to 18 months post-procedure.

Insomnia appeared in 61%, cognitive impairment and irritability in 38%, and more severe psychiatric issues such as psychosis and delirium were rarely considered.

Discover a recent study that found that smoking is associated with worse sexual function outcomes following radical prostatectomy.

Students using ChatGPT alone scored lower than those attending lectures suggesting that AI tools may not sufficiently support complex learning.

Discover a study where a checklist facilitated closed-loop management, ensuring continuity of care despite environmental changes.

Discover a study where researchers introduced a conceptual design for a toilet-mounted home device capable of non-invasively measuring urine flow, volume, and frequency.

This clinical trial evaluated the safety of stereotactic body radiotherapy to the prostate bed following radical prostatectomy.